Literature DB >> 25631804

Evaluation of portability and cost of a fluorescent PCR ribotyping protocol for Clostridium difficile epidemiology.

Jonathan N V Martinson1, Susan Broadaway1, Egan Lohman1, Christina Johnson1, M Jahangir Alam2, Mohammed Khaleduzzaman2, Kevin W Garey2, Jessica Schlackman3, Vincent B Young4, Kavitha Santhosh5, Krishna Rao6, Robert H Lyons7, Seth T Walk8.   

Abstract

Clostridium difficile is the most commonly identified pathogen among health care-associated infections in the United States. There is a need for accurate and low-cost typing tools that produce comparable data across studies (i.e., portable data) to help characterize isolates during epidemiologic investigations of C. difficile outbreaks and sporadic cases of disease. The most popular C. difficile-typing technique is PCR ribotyping, and we previously developed methods using fluorescent PCR primers and amplicon sizing on a Sanger-style sequencer to generate fluorescent PCR ribotyping data. This technique has been used to characterize tens of thousands of C. difficile isolates from cases of disease. Here, we present validation of a protocol for the cost-effective generation of fluorescent PCR ribotyping data. A key component of this protocol is the ability to accurately identify PCR ribotypes against an online database (http://walklab.rcg.montana.edu) at no cost. We present results from a blinded multicenter study to address data portability across four different laboratories and three different sequencing centers. Our standardized protocol and centralized database for typing of C. difficile pathogens will increase comparability between studies so that important epidemiologic linkages between cases of disease and patterns of emergence can be rapidly identified.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25631804      PMCID: PMC4365229          DOI: 10.1128/JCM.03591-14

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  19 in total

1.  In vitro antibiotic susceptibility profile of Clostridium difficile excluding PCR ribotype 027 outbreak strain in Hungary.

Authors:  Gabriella Terhes; Akiko Maruyama; Krisztina Latkóczy; Lenke Szikra; Marianne Konkoly-Thege; Gyula Princz; Elisabeth Nagy; Edit Urbán
Journal:  Anaerobe       Date:  2014-08-19       Impact factor: 3.331

2.  Modified multiple-locus variable-number tandem-repeat analysis for rapid identification and typing of Clostridium difficile during institutional outbreaks.

Authors:  George Broukhanski; Donald E Low; Dylan R Pillai
Journal:  J Clin Microbiol       Date:  2011-03-16       Impact factor: 5.948

3.  Multilocus variable-number tandem-repeat analysis for investigation of Clostridium difficile transmission in Hospitals.

Authors:  Jane W Marsh; Mary M O'Leary; Kathleen A Shutt; A William Pasculle; Stuart Johnson; Dale N Gerding; Carlene A Muto; Lee H Harrison
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

Review 4.  Emergence of Clostridium difficile-associated disease in North America and Europe.

Authors:  E J Kuijper; B Coignard; P Tüll
Journal:  Clin Microbiol Infect       Date:  2006-10       Impact factor: 8.067

5.  Antimicrobial-resistant strains of Clostridium difficile from North America.

Authors:  Fred C Tenover; Isabella A Tickler; David H Persing
Journal:  Antimicrob Agents Chemother       Date:  2012-03-12       Impact factor: 5.191

6.  Laboratory maintenance of Clostridium difficile.

Authors:  Joseph A Sorg; Sean S Dineen
Journal:  Curr Protoc Microbiol       Date:  2009-02

7.  PCR amplification of rRNA intergenic spacer regions as a method for epidemiologic typing of Clostridium difficile.

Authors:  C P Cartwright; F Stock; S E Beekmann; E C Williams; V J Gill
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

8.  Comparison of seven techniques for typing international epidemic strains of Clostridium difficile: restriction endonuclease analysis, pulsed-field gel electrophoresis, PCR-ribotyping, multilocus sequence typing, multilocus variable-number tandem-repeat analysis, amplified fragment length polymorphism, and surface layer protein A gene sequence typing.

Authors:  George Killgore; Angela Thompson; Stuart Johnson; Jon Brazier; Ed Kuijper; Jacques Pepin; Eric H Frost; Paul Savelkoul; Brad Nicholson; Renate J van den Berg; Haru Kato; Susan P Sambol; Walter Zukowski; Christopher Woods; Brandi Limbago; Dale N Gerding; L Clifford McDonald
Journal:  J Clin Microbiol       Date:  2007-11-26       Impact factor: 5.948

Review 9.  Current status of Clostridium difficile infection epidemiology.

Authors:  Fernanda C Lessa; Carolyn V Gould; L Clifford McDonald
Journal:  Clin Infect Dis       Date:  2012-08       Impact factor: 9.079

10.  Characterization of Clostridium difficile isolates using capillary gel electrophoresis-based PCR ribotyping.

Authors:  A Indra; S Huhulescu; M Schneeweis; P Hasenberger; S Kernbichler; A Fiedler; G Wewalka; F Allerberger; E J Kuijper
Journal:  J Med Microbiol       Date:  2008-11       Impact factor: 2.472

View more
  26 in total

1.  Characterization of Flagellum and Toxin Phase Variation in Clostridioides difficile Ribotype 012 Isolates.

Authors:  Brandon R Anjuwon-Foster; Natalia Maldonado-Vazquez; Rita Tamayo
Journal:  J Bacteriol       Date:  2018-06-25       Impact factor: 3.490

2.  Presence of multiple Clostridium difficile strains at primary infection is associated with development of recurrent disease.

Authors:  Anna M Seekatz; Emily Wolfrum; Christopher M DeWald; Rosemary K B Putler; Kimberly C Vendrov; Krishna Rao; Vincent B Young
Journal:  Anaerobe       Date:  2018-05-31       Impact factor: 3.331

3.  Clostridium difficile ribotype 027: relationship to age, detectability of toxins A or B in stool with rapid testing, severe infection, and mortality.

Authors:  Krishna Rao; Dejan Micic; Mukil Natarajan; Spencer Winters; Mark J Kiel; Seth T Walk; Kavitha Santhosh; Jill A Mogle; Andrzej T Galecki; William LeBar; Peter D R Higgins; Vincent B Young; David M Aronoff
Journal:  Clin Infect Dis       Date:  2015-03-31       Impact factor: 9.079

4.  Is Clostridium difficile infection a risk factor for subsequent bloodstream infection?

Authors:  Robert J Ulrich; Kavitha Santhosh; Jill A Mogle; Vincent B Young; Krishna Rao
Journal:  Anaerobe       Date:  2017-06-29       Impact factor: 3.331

5.  Molecular epidemiology of Clostridioides difficile in domestic dogs and zoo animals.

Authors:  M Jahangir Alam; Jacob McPherson; Julie Miranda; Allyson Thrall; Van Ngo; Rebecca Kessinger; Khurshida Begum; Maud Marin; Kevin W Garey
Journal:  Anaerobe       Date:  2019-06-15       Impact factor: 3.331

6.  Clostridioides difficile ribotypes isolated from domestic environment and from patients in Bangladesh.

Authors:  Mohammad Aminul Islam; Nayel D Kabir; M Moniruzzaman; Khurshida Begum; Dilruba Ahmed; A S G Faruque; Kevin W Garey; M Jahangir Alam
Journal:  Anaerobe       Date:  2019-02-19       Impact factor: 3.331

7.  Toxin A-negative toxin B-positive ribotype 017 Clostridium difficile is the dominant strain type in patients with diarrhoea attending tuberculosis hospitals in Cape Town, South Africa.

Authors:  B Kullin; J Wojno; V Abratt; S J Reid
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-09-30       Impact factor: 3.267

8.  In the Endemic Setting, Clostridium difficile Ribotype 027 Is Virulent But Not Hypervirulent.

Authors:  Samuel L Aitken; M Jahangir Alam; Mohammed Khaleduzzaman; Mohammed Khaleduzzuman; Seth T Walk; William L Musick; Vy P Pham; Jennifer L Christensen; Robert L Atmar; Yang Xie; Kevin W Garey
Journal:  Infect Control Hosp Epidemiol       Date:  2015-08-20       Impact factor: 3.254

9.  Elevated fecal calprotectin associates with adverse outcomes from Clostridium difficile infection in older adults.

Authors:  Krishna Rao; Kavitha Santhosh; Jill A Mogle; Peter D R Higgins; Vincent B Young
Journal:  Infect Dis (Lond)       Date:  2016-05-20

10.  Environmental transmission of Clostridioides difficile ribotype 027 at a long-term care facility; an outbreak investigation guided by whole genome sequencing.

Authors:  Bradley T Endres; Kierra M Dotson; Kelley Poblete; Jacob McPherson; Chris Lancaster; Eugénie Bassères; Ali Memariani; Sandi Arnold; Shawn Tupy; Conner Carlsen; Bonnie Morehead; Sophia Anyatonwu; Christa Cook; Khurshida Begum; M Jahangir Alam; Kevin W Garey
Journal:  Infect Control Hosp Epidemiol       Date:  2018-09-26       Impact factor: 3.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.